Lexeo Therapeutics, Inc. (LXEO) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $63.00M | +79.9% |
| 2024 | $35.01M | -71.2% |
| 2023 | $121.47M | +57.1% |
| 2022 | $77.33M | -43.1% |
| 2021 | $135.86M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $63.00M | +79.9% |
| 2024 | $35.01M | -71.2% |
| 2023 | $121.47M | +57.1% |
| 2022 | $77.33M | -43.1% |
| 2021 | $135.86M | — |